Andrew McKnight

Andrew McKnight is an accomplished executive in the field of immunology and biotherapeutics with extensive experience in research leadership. Currently serving as Executive Director at Sanofi since July 2023, Andrew previously held various senior roles at Kyowa Kirin, Inc., including Chief Research Officer and President, directing research on autoimmune and inflammatory diseases. Andrew's background includes leadership positions at AnaptysBio, Pfizer Biotherapeutics R&D, and UCB Celltech, focusing on therapeutic antibody development and target identification. Educational achievements include a D.Phil. in Molecular Immunology from the University of Oxford and a B.Sc. in Immunology from the University of Glasgow. Andrew's expertise encompasses project leadership, business development, external innovation, and collaboration with leading researchers in the field.